ABSTRACT
Cardiomyopathic disease is the most common diagnosis leading to heart transplantation in pediatric recipients. In transplanted infants less than 1 year of age about 30% had the diagnosis of myopathy. For the childhood age years, the percentage increases to 52% and for the adolescent population about 62% (1). The current pediatric transplant survival curves suggest a graft half-life of approximately 15 years and probably longer for infant and childhood recipients (1). These results are encouraging for patients who have undergone orthotopic cardiac transplantation.
